RESULTS OF A PHASE 3 RANDOMIZED CONTROLLED STUDY EVALUATING THE EFFICACY AND SAFETY OF IDELALISIB (IDELA) IN COMBINATION WITH OFATUMUMAB (OFA) FOR PREVIOUSLY TREATED CHRONIC LYMPHOCYTIC LEUKEMIA (CLL)
暂无分享，去创建一个
Jeffrey A Jones | F. Bosch | P. Feugier | F. Awan | A. Schuh | Jennifer R. Brown | L. Ysebaert | T. Robak | K. Morris | A. Skotnicki | A. Nathwani | L. Sanhes | C. Owen | N. Wagner-Johnston | A. Menter | L. Larratt | J. García-Marco | U. Hahn | J. Loscertales | L. Dreiling | R. Dubowy | E. Vandenberghe | X. Badoux | K. Taylor | P. Cannell | M. Wach | E. Pulczynski | S. Peterman | Yoonjin Cho | Zini Jm | Dihuydy M-S.